STAASTAAR Surgical Company
Is it growing?
Neither accelerating nor breaking down: revenue growing +51% year on year and operating margin widening (+63.1 points), but earnings down −104% year on year.
Trailing-twelve-month revenue vs a year earlier, from the company's own filings. Five-year pace: +10% a year.
Trailing-twelve-month earnings per share against a year earlier. Growing slower than revenue, so the growth is costing something.
Trailing-twelve-month operating margin, -0.2% now against -63.2% a year earlier.
All from SEC EDGAR, as of Jul 3, 2026.
Where this answer is blind. These are trailing numbers from the filings, not forecasts: an acquisition or a one-off year can flatter them, so check the quarters.
Is STAA growing?
STAAR Surgical Company has grown revenue 9.2% a year over three years and 10% a year over five, with earnings per share compounding at −46%.
Revenue growth, 3-year annual rate · Medical Instruments & Supplies median +9.8% · steady growth, ahead of inflation · compounded from trailing twelve-month revenue
- Revenue growth, 5-year rate
- +10%
Revenue growth, 5-year rate · +9.2% over three · growth has slowed since the five-year average
- Earnings per share, 3-year rate
- −46%
Earnings per share, 3-year rate · revenue +9.2% · earnings lagged revenue: the growth is costing something
- Years of annual history on file
- 17
Years of annual history on file · FY2009 to FY2025, as filed
Details›
- Revenue FY2021
- $230M
- Revenue FY2022
- $239M
- Revenue FY2023
- $322M
- Revenue FY2024
- $314M
- Revenue FY2025
- $239M
Annual income statements as filed with the SEC.
Medical Instruments & Supplies
Ranks #9 of 21 by RyuScore